Koers Thermo Fisher Scientific Inc. Wiener Boerse
Aandelen
TMOF
US8835561023
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
527,1 EUR | -3,07% | -0,80% | +12,82% |
Omzet 2024 * | 43,02 mld. 39,63 mld. | Omzet 2025 * | 46,1 mld. 42,46 mld. | Marktkapitalisatie | 223 mld. 205 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6,15 mld. 5,66 mld. | Nettowinst (verlies) 2025 * | 6,97 mld. 6,42 mld. | EV/omzet 2024 * | 5,73 x |
Nettoschuld 2024 * | 23,49 mld. 21,64 mld. | Nettoschuld 2025 * | 19,14 mld. 17,63 mld. | EV/omzet 2025 * | 5,25 x |
K/w-verhouding 2024 * |
36,7
x | K/w-verhouding 2025 * |
31,5
x | Werknemers | 122.000 |
Dividendrendement 2024 * |
0,26% | Dividendrendement 2025 * |
0,28% | Vrij verhandelbaar | 86,04% |
Recentste transcriptie over Thermo Fisher Scientific Inc.
1 dag | -3,07% | ||
1 week | -0,80% | ||
Lopende maand | +1,47% | ||
1 maand | +1,46% | ||
3 maanden | +4,46% | ||
6 maanden | +21,38% | ||
Lopend jaar | +12,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-11-01 |
Director of Finance/CFO | 57 | 01-06-01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-11-01 |
C. Harris
BRD | Director/Board Member | 67 | 30-03-12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01-03-22 |
Datum | Koers | Variatie |
---|---|---|
23-05-24 | 543,8 | -0,87% |
27-05-24 | 537,1 | -0,15% |
24-05-24 | 537,9 | -1,08% |
23-05-24 | 543,8 | -0,87% |
22-05-24 | 548,6 | +0,98% |
slotkoers Wiener Boerse, 23 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,83% | 195 mld. | |
+18,87% | 144 mld. | |
+30,03% | 111 mld. | |
+2,32% | 65,19 mld. | |
+14,15% | 53,02 mld. | |
+2,68% | 50,28 mld. | |
+6,60% | 44,15 mld. | |
+1,85% | 36,45 mld. | |
+20,43% | 31,33 mld. |